Clinical-Stage Platforms
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 TMO | Thermo Fisher Scientific, Inc. | $183.0b | $471.55 | -2.2% | 1.7M |
 A | Agilent Technologies Inc. | $38.2b | $134.28 | -3.0% | 2.2M |
 WAT | Waters Corp | $37.7b | $364.80 | -3.1% | 676.5K |
 IQV | IQVIA Holdings Inc. | $30.4b | $183.45 | -1.8% | 1.3M |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $24.7b | $55.88 | +1.6% | 6.0M |
 WST | West Pharmaceutical Services, Inc. | $22.8b | $314.50 | -0.9% | 636.0K |
 ASND | Ascendis Pharma A/S Ordinary Share | $13.8b | $210.31 | -3.9% | 592.7K |
 MEDP | Medpace Holdings, Inc. Common Stock | $12.8b | $454.58 | -0.9% | 190.6K |
 RVTY | Revvity, Inc. | $11.7b | $98.37 | -3.9% | 868.6K |
 ICLR | Icon Plc | $10.4b | $149.42 | -2.2% | 1.3M |
 BRKR | Bruker Corporation | $9.0b | $56.39 | -6.0% | 3.6M |
 CRL | Charles River Laboratories International, Inc. | $8.7b | $180.00 | -3.1% | 519.3K |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $8.1b | $317.30 | +4.3% | 59 |
 TECH | Bio-Techne Corp. | $8.1b | $51.98 | -2.3% | 2.9M |
 HALO | Halozyme Therapeutics, Inc. | $7.9b | $71.53 | -0.1% | 1.1M |
 QGEN | QIAGEN N.V. | $7.5b | $36.68 | -2.3% | 1.4M |
 RGEN | Repligen Corp | $7.0b | $122.37 | -3.3% | 693.6K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.7b | $74.12 | -0.7% | 639.5K |
 CELC | Celcuity Inc. Common Stock | $6.5b | $88.17 | -4.7% | 1.7M |
 AVTR | Avantor, Inc. | $6.2b | $9.16 | -3.8% | 9.5M |
 CGON | CG Oncology, Inc. Common stock | $5.5b | $53.72 | -4.2% | 967.3K |
 LGND | Ligand Pharmaceuticals Inc. | $4.6b | $236.92 | +0.4% | 174.9K |
 MANE | Veradermics, Incorporated | $4.2b | $92.00 | -9.1% | 548.8K |
 TWST | Twist Bioscience Corporation Common Stock | $4.2b | $69.19 | -6.4% | 2.5M |
 OGN | Organon & Co. | $3.5b | $13.36 | -0.3% | 2.2M |
 RLAY | Relay Therapeutics, Inc. Common Stock | $3.1b | $13.52 | -7.0% | 6.1M |
 KOD | Kodiak Sciences Inc Common Stock | $2.3b | $31.00 | -9.3% | 1.5M |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $13.34 | -4.2% | 729.3K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $2.0b | $26.64 | -2.0% | 1.5M |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.9b | $3.31 | -12.8% | 26.9M |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.9b | $5.61 | -11.9% | 8.9M |
 ZYME | Zymeworks Inc. | $1.8b | $24.04 | -4.3% | 464.8K |
 NRIX | Nurix Therapeutics, Inc. Common stock | $1.8b | $14.65 | -4.1% | 1.6M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $1.7b | $8.22 | -9.1% | 6.7M |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.7b | $12.89 | -12.3% | 1.6M |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.7b | $16.36 | -5.8% | 950.3K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.5b | $87.08 | -4.6% | 417.4K |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.5b | $16.11 | -6.6% | 1.0M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.4b | $20.00 | -2.0% | 356.2K |
 HROW | Harrow, Inc. Common Stock | $1.3b | $33.22 | -4.2% | 649.5K |
 SDGR | Schrodinger, Inc. Common Stock | $1.1b | $14.36 | -9.4% | 1.4M |
 OPK | Opko Health Inc. | $1.1b | $1.43 | -2.0% | 3.9M |
 ABSI | Absci Corporation Common Stock | $1.1b | $6.38 | -13.1% | 5.2M |
 ALVO | Alvotech Ordinary Shares | $1.0b | $3.54 | -5.2% | 694.1K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.68 | -9.5% | 4.7M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $22.73 | +0.3% | 402.7K |
 CERT | Certara, Inc. Common Stock | $0.9b | $5.37 | -4.4% | 5.2M |
 VOR | Vor Biopharma Inc. Common Stock | $0.8b | $13.16 | -8.1% | 597.3K |
 PHAT | Phathom Pharmaceuticals, Inc. Common Stock | $0.8b | $10.14 | +2.8% | 1.2M |